Changes in symptoms of depression with weight loss. The predictive properties of the C-SSRS have mainly been evaluated in young US populations. Retrieved from FDA website: įaulconbridge, L. Suicidality issues in clinical trials: Columbia suicidal adverse event identification in PDA safety analysis. Columbia Classification Algorithm of Suicide Assessment (C-CASA): Classification of suicidal events in the FDA’s pediatric suicidal risk analysis of antidepressants. The BDI test is widely known and has been tested for content, concurrent, and construct validity.High concurrent validity ratings are given between the BDI and other depression instruments as the Minnesota Multiphasic Personality Inventory and the Hamilton Depression Scale 0. Current Treatment Opinions in Neurology, 11(5), 371–376. New perspectives on assessment of suicide risk.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |